Hilltop National Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Hilltop National Bank's BMY Position: Q2 2026 in Review
Hilltop National Bank reduced its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, selling an estimated $167K and leaving 6,422 shares worth $370K. The position accounts for 0.08% of the portfolio, ranked #170.
Hilltop National Bank first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $565K in Q1 2026. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hilltop National Bank held 6,422 shares of Bristol-Myers Squibb worth $370K as of Q2 2026.
- Hilltop National Bank sold 2,900 Bristol-Myers Squibb shares in Q2 2026, an estimated $167K.
- Bristol-Myers Squibb made up 0.08% of Hilltop National Bank's portfolio in Q2 2026, its #170 holding.
- Hilltop National Bank first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
- Hilltop National Bank's Bristol-Myers Squibb position peaked at $565K in Q1 2026.
- 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.